Darunavir®/Ritonavir® monotherapy: Efficacy, safety and cost reduction.

Autor:	Anonymous1, Rubio Rubio, M.V.1, Lambán Ibor, E.1, Martínez Pagán, E.1, Martín Durán, C.1, Artajona Rodrigo, E.1, Cuesta, J.2
Zdroj:	European Journal of Internal Medicine. Oct2013, Vol. 24, pe201-e201. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect